Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 160
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Impact of Soylent Consumption on Human Microbiome Composition

As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

A Leap Forward to Cure a Neglected Disease

The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

Do fungi exposed to toxic waste produce novel antimicrobial agents?

We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

Backer Badge Funded